MedPath

Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

Ownership
-
Established
1993-08-12
Employees
548
Market Cap
-
Website
www.xf-pharma.com
Introduction

The company is a pharmaceutical company focusing on household topical medicines and consumer pharmaceuticals. It is committed to developing and providing safe and affordable topical medicines and consumer pharmaceuticals for thousands of households. It has many brands such as “Xinlong”, and its products are in a leading position in the national market share. The company's main business is R&D, production and sales of topical drugs, and the products have strong competitiveness and high market recognition. The company's digestive products mainly include caserol, glycerin enema, etc., which can be used to treat constipation (including constipation in children), etc. The company's skin products include calamine lotion, zinc oxide ointment, sulfur ointment, antispasmodic and analgesic tincture, frostbite cream, compound menthol ointment, urea vitamin E cream, boric acid lotion, benzalkonium bromide tincture, white flower oil, etc., which can be used to treat various common diseases such as dermatitis, eczema, acne and decubitus, frostbite, sunburn, etc., and can also meet the daily care needs of the company; These products mainly include iodioglycerin, furacin nasal drops, ofloxacin ear drops, etc., which can be used for oral ulcers, swollen gums, periodontitis, Common diseases such as rhinitis, nasal congestion, and otitis media. The company's shares were listed on the main board of the Shanghai Stock Exchange on August 26, 2024.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

64

NMPA:64

Drug Approvals

Ichthammol Ointment

Product Name
鱼石脂软膏
Approval Number
国药准字H31021307
Approval Date
Jul 30, 2024
NMPA

甘油灌肠剂

Approval Number
国药准字H31021305
Approval Date
Jul 24, 2024
NMPA

炉甘石洗剂

Approval Number
国药准字H31022790
Approval Date
Jul 22, 2024
NMPA

复方苦参水杨酸散

Approval Number
国药准字H31022491
Approval Date
Jul 22, 2024
NMPA

氧化锌软膏

Approval Number
国药准字H31021231
Approval Date
Jul 22, 2024
NMPA

碘酊

Approval Number
国药准字H31021416
Approval Date
Jul 4, 2024
NMPA

复方间苯二酚水杨酸酊

Approval Number
国药准字H31022946
Approval Date
Jul 4, 2024
NMPA

Econazole Nitrate Liquor

Product Name
硝酸益康唑癣药水
Approval Number
国药准字H31021306
Approval Date
May 11, 2024
NMPA

硼酸洗液

Approval Number
国药准字H31022883
Approval Date
May 7, 2024
NMPA

樟脑苯酚溶液

Approval Number
国药准字H31022493
Approval Date
Apr 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.